130 related articles for article (PubMed ID: 9056584)
1. Discussion of individual bioequivalence by M.-L. Chen.
Gould AL
J Biopharm Stat; 1997 Mar; 7(1):23-9. PubMed ID: 9056584
[TBL] [Abstract][Full Text] [Related]
2. On TIER method for assessment of individual bioequivalence.
Ju HL
J Biopharm Stat; 1997 Mar; 7(1):63-85. PubMed ID: 9056589
[TBL] [Abstract][Full Text] [Related]
3. Types of bioequivalence and related statistical considerations.
Hauck WW; Anderson S
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
[TBL] [Abstract][Full Text] [Related]
4. Extension to the use of tolerance intervals for the assessment of individual bioequivalence.
Esinhart JD; Chinchilli VM
J Biopharm Stat; 1994 Mar; 4(1):39-52. PubMed ID: 8019583
[TBL] [Abstract][Full Text] [Related]
5. A two one-sided tests procedure for assessment of individual bioequivalence.
Liu J; Chow SC
J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
[TBL] [Abstract][Full Text] [Related]
6. Individual bioequivalence--a European perspective.
Steinijans VW; Hauschke D
J Biopharm Stat; 1997 Mar; 7(1):31-4. PubMed ID: 9056585
[TBL] [Abstract][Full Text] [Related]
7. Mean difference vs. variability reduction: tradeoffs in aggregate measures for individual bioequivalence. FDA Individual Bioequivalence Working Group.
Hauck WW; Chen ML; Hyslop T; Patnaik R; Schuirmann D; Williams R
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):535-41. PubMed ID: 8996848
[TBL] [Abstract][Full Text] [Related]
8. A distribution-free procedure for the statistical analysis of bioequivalence studies.
Hauschke D; Steinijans VW; Diletti E
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S37-43. PubMed ID: 1601530
[TBL] [Abstract][Full Text] [Related]
9. Update on the statistical analysis of bioequivalence studies.
Steinijans VW; Hauschke D
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S45-50. PubMed ID: 1601531
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis for bioequivalence review.
Chow SC; Liu J
J Biopharm Stat; 1997 Mar; 7(1):97-111. PubMed ID: 9056591
[TBL] [Abstract][Full Text] [Related]
11. Some thoughts on individual bioequivalence.
Liu J; Chow SC
J Biopharm Stat; 1997 Mar; 7(1):41-8. PubMed ID: 9056587
[No Abstract] [Full Text] [Related]
12. Bioequivalence and intrasubject variability.
Liu JP
J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
[TBL] [Abstract][Full Text] [Related]
13. A group sequential approach to crossover trials for average bioequivalence.
Hauck WW; Preston PE; Bois FY
J Biopharm Stat; 1997 Mar; 7(1):87-96. PubMed ID: 9056590
[TBL] [Abstract][Full Text] [Related]
14. A three-step procedure for assessing bioequivalence in the general mixed model framework.
Vuorinen J; Turunen J
Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
[TBL] [Abstract][Full Text] [Related]
15. A comment on so-called individual criteria of bioequivalence.
Wellek S
J Biopharm Stat; 1997 Mar; 7(1):17-21. PubMed ID: 9056583
[TBL] [Abstract][Full Text] [Related]
16. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar.
Schall R
Biometrics; 1995 Jun; 51(2):615-26. PubMed ID: 7662849
[TBL] [Abstract][Full Text] [Related]
17. Some issues for the consideration of individual bioequivalence.
Endrenyi L
J Biopharm Stat; 1997 Mar; 7(1):35-9. PubMed ID: 9056586
[No Abstract] [Full Text] [Related]
18. Commentary on individual bioequivalence by M.-L. Chen.
Hauck WW; Anderson S
J Biopharm Stat; 1997 Mar; 7(1):13-6. PubMed ID: 9056582
[No Abstract] [Full Text] [Related]
19. On population and individual bioequivalence.
Schall R; Luus HG
Stat Med; 1993 Jun; 12(12):1109-24. PubMed ID: 8210816
[TBL] [Abstract][Full Text] [Related]
20. The impact of outlying subjects on decision of bioequivalence.
Ki FY; Liu JP; Wang W; Chow SC
J Biopharm Stat; 1995 Mar; 5(1):71-94. PubMed ID: 7613561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
